Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes

Journal of Virology

Volumn 77, Issue 20, 2003, Pages 10872-10880

  Vigouroux, Stéphane ^a   Yvon, Eric ^a   Wagner, Hans Joachim ^a   Biagi, Ettore ^a   Dotti, Gianpietro ^a   Sili, Uluhan ^a   Lira, Cecilia ^a   Rooney, Cliona M ^a   Brenner, Malcolm K ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; JAGGED1; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; NOTCH RECEPTOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CANDIDA; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOBLASTOID CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE;

ADULT; ANTIGENS, VIRAL; B-LYMPHOCYTES; CALCIUM-BINDING PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, NOTCH; T-LYMPHOCYTES;

EID: 0141566334     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.20.10872-10880.2003     Document Type: Article

References (47)

1. Artavanis-Tsakonas, S., K. Matsuno, and M. E. Fortini. 1995. Notch signaling. Science 268:225-232.
2. Bartholomew, A., C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, A. Moseley, and R. Hoffman. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30:42-48.
3. Deftos, M. L., and M. J. Bevan. 2000. Notch signaling in T cell development. Curr. Opin. Immunol. 12:166-172.
4. + regulatory T cells in vivo in humans. Blood 100:174-177.
5. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303-1310.
6. + suppressor T cells in vivo. Nat. Immunol. 3:33-41.
7. Gilliet, M., and Y. J. Liu. 2002. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195:695-704.
8. + T cells, IL-2, and NK cell-derived TGF-β: contrasting effects of anti-CD2 and anti-CD3. J. Immunol. 160:2248-2254.
9. Greenwald, I., and G. M. Rubin. 1992. Making a difference: the role of cell-cell interactions in establishing separate identities for equivalent cells. Cell 68:271-281.
10. Groux, H. 2001. An overview of regulatory T cells. Microbes Infect. 3:883-889.
11. + T cells. Int. Immunol. 12:177-185.
12. Jarriault, S., O. Le Bail, E. Hirsinger, O. Pourquie, F. Logeat, C. F. Strong, C. Brou, N. G. Seidah, and A. Israël. 1998. Delta-1 activation of Notch-1 signaling results in HES-1 transactivation. Mol. Cell. Biol. 18:7423-7431.
13. Jones, P., G. May, L. Healy, J. Brown, G. Hoyne, S. Delassus, and T. Enver. 1998. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood 92:1505-1511.
14. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213-1222.
15. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285-1294.
16. Karanu, F. N., B. Murdoch, L. Gallacher, D. M. Wu, M. Koremoto, S. Sakano, and M. Bhatia. 2000. The Notch ligand Jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192:1365-1372.
17. Kimble, J., and P. Simpson. 1997. The LIN-12/Notch signaling pathway and its regulation. Annu. Rev. Cell Dev. Biol. 13:333-361.
18. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169:4712-4716.
19. Lakhdar, M., A. Senik, and W. H. Fridman. 1984. Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cells. Cell Immunol. 83:414-421.
20. Lie, Y. S., and C. J. Petropoulos. 1998. Advances in quantitative PCR technology: 5′ nuclease assays. Curr. Opin. Biotechnol. 9:43-48.
21. -ΔΔ C(T) method. Methods 25:402-408.
22. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816-822.
23. + regulatory T cells. J. Immunol. 169:3710-3716.
24. Miller, J. F., and A. Basten. 1996. Mechanisms of tolerance to self. Curr. Opin. Immunol. 8:815-821.
25. Milner, L. A., and A. Bigas. 1999. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood 93:2431-2448.
26. + cells: a naturally occurring population of regulatory T cells. Blood 98:2736-2744.
27. + regulatory T cells. Curr. Opin. Immunol. 13:644-649.
28. Rickinson, A. B., S. P. Lee, and N. M. Steven. 1996. Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr. Opin. Immunol. 8:492-497.
29. Robey, E. 1997. Notch in vertebrates. Curr. Opin. Genet. Dev. 7:551-557.
30. Robey, E. 1999. Regulation of T cell fate by Notch. Annu. Rev. Immunol. 17:283-295.
31. Roncarolo, M. G., R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68-79.
32. Rooney, C. M., C. A. Smith, C. Y. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9-13.
33. Rooney, C. M., C. A. Smith, C. Y. Ng, S. K. Loftin, J. W. Sixbey, Y. Gan, D. K. Srivastava, L. C. Bowman, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1998. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549-1555.
34. + cytotoxic T lymphocytes. J. Virol. 74:4729-4737.
35. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1-8.
36. Shayakhmetov, D. M., and A. Lieber. 2000. Dependence of adenovirus infectivity on length of the fiber shaft domain. J. Virol. 74:10274-10286.
37. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31:1247-1254.
38. Stewart, J. P., and C. M. Rooney. 1992. The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses Virology 191:773-782.
39. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310.
40. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
41. Varnum-Finney, B., L. E. Purton, M. Yu, C. Brashem-Stein, D. Flowers, S. Staats, K. A. Moore, R. Le, I., R. Mann, G. Gray, S. Artavanis-Tsakonas, and I. D. Bernstein. 1998. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 91:4084-4091.
42. Varnum-Finney, B., L. Xu, C. Brashem-Stein, C. Nourigat, D. Flowers, S. Bakkour, W. S. Pear, and I. D. Bernstein. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:1278-1281.
43. + regulatory T cells from human peripheral blood. J. Immunol. 166:7282-7289.
44. Yamamoto, N., S. Yamamoto, F. Inagaki, M. Kawaichi, A. Fukamizu, N. Kishi, K. Matsuno, K. Nakamura, G. Weinmaster, H. Okano, and M. Nakafuku. 2001. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J. Biol. Chem. 276:45031-45040.
45. Yotnda, P., H. Onishi, H. E. Heslop, D. Shayakhmetov, A. Lieber, M. Brenner, and A. Davis. 2001. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 8:930-937.
46. +. J. Immunol. 169:4183-4189.
47. Zinkernagel, R. M., S. Ehl, P. Aichele, S. Oehen, T. Kundig, and H. Hengartner. 1997. Antigen localisation regulates immune responses in a doseand time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156:199-209.